Why do Airlines Overbook in the ist place . We will try and find out. Good morning, welcome to the programme. We are alive until 11 am, we will bring you the breaking news and developing stories and we are keen to hear from you. We will talk to former executioner who will save why he is opposed to the Death Penalty, that as new figures show the number of times its used around the number of times its used around the world is actually falling. And you may be surprised that the country for the most executions are still carried out, we will bring you the news after 10 am. If you are getting in touch, you can do so on the usual ways. Just trying to tell you our programme has been nominated for a Ba Fta For Programme has been nominated for a bafta for our coverage of the foot dollars abuse story back in november. The competition is very tough footballers. More than 900 Adult Social Care workers a day left theirjob in england last year. Around 60 of those who quit left the Adult Social Care p
Is that reoffending rates are rising, crime levels are rising, something is clearly not working. And this subtle removal of the word perhaps signifies the direction of this government and what they want to do and how they want to reform the Justice System in this country bridge be working. Liz truss will be at used by some of going soft . at used by some of going soft . |j would at used by some of going soft . would say it is a badge of honour for her that she is being attacked by mick davies, the tory mp. Hes at using her of by mick davies, the tory mp. Hes at using herof being by mick davies, the tory mp. Hes at using her of being one of the liberal lefties, as he puts it. I dont know what are the sort of lefties there are full stop it is a weird phrase. According to mr davies, he says people having their freedom taken away is a punishment in itself. Too many people, it is not. I really cant disagree with that more. As you said, laura, the point of prison is to stop people going back
Clinical trials are using AI to handle large and complex volumes of data to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data.
(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer drug Keytruda, sending the company's shares up more than 2% before the bell. Keytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past few years and is expected to top $30 billion in sales by 2026 before losing exclusivity toward the end of the decade. The drug is seeing growth from use for additional types of cancers as well as higher patient demand, Chief Financial Officer Caroline Litchfield said.